Vyome (HIND) news
Recent news
Corrected-Vyome Holdings Inc Q2 EPS USD -0.1 (corrects amount)
Vyome Holdings Inc. reported a corrected net loss of $0.10 per share for the second quarter of 2026, according to a recent filing [1]. This revision reflects an adjustment to previously reported figures, providing a more accurate representation of the company’s financial performance during the…
AInvest Wire · 6d agoVyome Holdings Inc Q2 EPS USD 0.1
AInvest Wire · 6d agoVyome granted Chinese patent strengthening immuno-inflammation portfolio
Vyome Therapeutics has been granted a patent in China for a key immuno-inflammation-related asset, further strengthening its intellectual property (IP) portfolio in a critical market. The patent, issued by the China National Intellectual Property Administration (CNIPA), supports Vyome’s ongoing…
AInvest Wire · Jul 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.